An association study between CHEK2 gene mutations and susceptibility to breast cancer.

Jalilvand, Manizheh; Oloomi, Mana; Najafipour, Reza; Alizadeh, Safar Ali; Saki, Najmaldin; Rad, Fatemeh Samiee; Shekari, Mohammad

Jalilvand, Manizheh; Oloomi, Mana; Najafipour, Reza; Alizadeh, Safar Ali; Saki, Najmaldin; Rad, Fatemeh Samiee; Shekari, Mohammad.

Afiliação

Jalilvand M; Department of Medical Genetics, Faculty of Medicine, Hormozgan University of Medical Sciences, Bandar-Abbas, Iran.
Oloomi M; Department of Molecular Biology, Pasture Institute , Tehran, Iran.
Najafipour R; Department of Biochemistry and Genetics, Cellular and Molecular Research Center, Qazvin University of Medical Sciences, Qazvin, Iran.
Alizadeh SA; Department of Biochemistry and Genetics, Cellular and Molecular Research Center, Qazvin University of Medical Sciences, Qazvin, Iran.
Saki N; Health Research Institute, Thalassemia and Hemoglobinopathy Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Rad FS; Department of Pathology, Metabolic Disease Research Center, Qazvin University of Medical Sciences, Qazvin, Iran.
Shekari M; Department of Medical Genetics, Faculty of Medicine, Hormozgan University of Medical Sciences, Bandar-Abbas, Iran.

Comp Clin Path ; 26(4): 837-845, 2017.

Article em En | MEDLINE | ID: mdl-28680382

Palavras-chave

Breast cancer; CHEK2; Mutation

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Comp Clin Path Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Irã País de publicação: Reino Unido

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google